Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether free at the point of use care under the proposed National Care Service will apply to (a) adults under the age of 65 with assessed care needs, and (b) whether the entitlement will cover accommodation and living costs, in addition to personal care.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
Baroness Casey has made clear that one of the core purposes of the Big Conversation on Care that she is leading is to hear from people, families, carers, and others with direct, real-life experience of the current social care system, so she can reflect those experiences in her recommendations for reform. That will include individuals aged under 65 years old in need of care, and the individuals caring for them. The Government will wait for the outcome of Baroness Casey’s review before taking any final decisions.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment her Department has made of the potential benefits of funding immunotherapy research for people with early-stage type 1 diabetes.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Department delivers research into the diagnosis, treatment, and management of type 1 diabetes through the research infrastructure of the National Institute for Health and Care Research (NIHR), comprised of biomedical research centres (BRCs), clinical research facilities (CRFs), and its Research Delivery Network (RDN). Through this infrastructure:
The NIHR continues to welcome high-quality applications for research into type 1 diabetes, which will be assessed against its normal criteria, and judged in open competition.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment her department has made of the potential impact of funding for earlier diagnosis and specialist heart failure services on NHS expenditure associated with emergency admissions.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department plans to pilot the provision of NT-proBNP point-of-care testing in community pharmacies for people presenting with symptoms of heart failure.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
On the provision of NT-proBNP point-of-care testing, I refer the Hon. Member to the answer provided on 5 June 2025 in response to Question 54244. More broadly, the Cardiovascular Diesease Modern Service Framework sets out the Department's approach to prevention and reduced hospital admissions and is available at the following link:
https://www.gov.uk/government/publications/cardiovascular-disease-modern-service-framework
However, the Department does not hold the specific estimate requested.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help improve dementia diagnosis, treatment and long-term care provision for military veterans in (i) Broxtowe constituency and (ii) Nottinghamshire.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
The Government is proud of the courage and dedication of our Armed Forces. It is our duty to ensure that those that have been injured whilst serving in the Armed Forces, whether physically or mentally, receive the very best possible care.
Local integrated care boards commission dementia healthcare services and are expected to deliver services based on local population needs, taking account of National Institute for Health and Care Excellence guidelines.
We will publish the first ever Modern Service Framework for Frailty and Dementia to set a clear direction and a long-term blueprint to improve outcomes for people with dementia. It will seek to reduce unwarranted variation and narrow inequality for those living with dementia.
We are engaging with a wide group of partners to understand what should be included to ensure the best outcomes for people living with frailty and dementia.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment she has made of the adequacy of support available to people with (a) multiple sclerosis and (b) other progressive neurological conditions in (i) Broxtowe constituency, (ii) Nottinghamshire and (iii) England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to increase capacity within NHS neurology services in (i) Broxtowe, (ii) Nottinghamshire, and (iii) England.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what support her Department is providing to Integrated Care Systems to ensure people with multiple sclerosis receive the best possible care.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The Government is committed to improving access to high‑quality care and treatment for people with multiple sclerosis (MS) and other progressive neurological conditions, including in Broxtowe and Nottinghamshire. NHS England has published a service specification for specialised neurology services, which aims to ensure that patients receive coordinated, multidisciplinary care and timely access to appropriate treatments.
The National Institute for Health and Care Excellence has issued guidance on the use of disease‑modifying therapies for MS, supporting clinicians to offer clinically and cost‑effective treatments based on the best available evidence. NHS England also supports the implementation of treatment algorithms to promote consistent prescribing and reduce unwarranted variation in access to high‑efficacy therapies.
In addition, programmes such as Getting It Right First Time are helping to improve outcomes and reduce variation in neurological care across the country. NHS RightCare’s progressive neurological conditions toolkit supports improved outcomes for people with MS by helping local systems identify and address unwarranted variation in care, and by setting out evidence‑based pathways for timely diagnosis, treatment, and ongoing management. The toolkit promotes a coordinated, multidisciplinary approach and emphasises proactive management of symptoms and complications.
The 10-Year Health Plan will also support improved care and outcomes for people with MS by focusing on earlier diagnosis, more timely access to specialist treatment, and more coordinated, community‑based care. It will prioritise reducing unwarranted variation in services and strengthening multidisciplinary support, helping people with MS to manage their condition more effectively and maintain their quality of life.
Integrated care boards are responsible for commissioning services to meet the needs of their local populations and are expected to have regard to National Institute for Health and Care Excellence and other guidance to ensure patients can access high‑quality care and treatment.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the judgment in A Reference by the Attorney General for Northern Ireland of a devolution issue under paragraph 34 of Schedule 10 to the Northern Ireland Act [2026] UKSC 16, what steps her Department has taken to support local authorities in respect to people who were previously subject to Deprivation of Liberty Safeguards (DoLS) authorisations but who, following the that judgment, now no longer fall within the scope of DoLS.
Answered by Alison McGovern - Minister of State (Department of Health and Social Care)
The Department has carefully considered the Supreme Court’s judgment and, on 15 June 2026, published an update for the health and care sector, available at the following link:
The update sets out the implications of the judgment and the factors to consider when assessing whether an individual is deprived of their liberty. It also advises local authorities and care providers to begin planning how to prioritise their current caseload, including existing authorisations, individuals on waiting lists, and new referrals. The Department will publish further interim guidance this autumn to help the sector apply the judgment in practice.
The deprivation of liberty safeguards (DoLS) system will continue to apply, in line with the changes required by the Supreme Court judgment. DoLS are only one of several protections in place. Additional safeguards include the Mental Capacity Act, local authority safeguarding duties required by the Care Act 2014, and common law duties of care, some of which also include the right to an advocate.
Asked by: Juliet Campbell (Labour - Broxtowe)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the potential merits of publishing consistent data on (a) recurrence and (b) longer-term survival rates for secondary breast cancer.
Answered by James Frith - Parliamentary Under-Secretary (Department of Health and Social Care)
The National Cancer Plan for England, published in February this year, committed to define and count recurrent cancers, starting with breast cancer. The National Disease Registration Service is working towards publishing a baseline figure of metastatic breast cancer patients in the last quarter of 2026 as per the commitment in the plan.
Through this National Cancer Plan action, we will ensure that every person with secondary breast cancer has faster diagnosis and treatment, access to the latest treatments and technology, and high-quality support throughout their journey, while we work to drive up this country’s cancer survival rates.
NHS England and other National Health Service organisations, nationally and locally, publish information on the signs and symptoms of many different types of cancer, including breast cancer. This information can be found at sources including the NHS website, at the following link:
NHS breast screening for women at very high risk (VHR) starts earlier and is more frequent than those not at VHR. Guidance on eligibility for VHR screening is available at the following link:
https://www.gov.uk/government/publications/breast-screening-higher-risk-women-surveillance-protocols
Women at VHR of breast cancer are now identified within the NHS National Inherited Cancer Predisposition Registry, and referred into the NHS Breast Screening Programme, which has enabled reconciliation to ensure that all identified women are safely referred into the programme. This is a step towards a fully electronic referral VHR process into the NHS Breast Screening Programme.